Revision LR Femoral Stem for Hip Replacement

A Retrospective and Prospective Clinical Study Evaluating Safety and Performance of Revision LR Stem in Total Hip Arthroplasty (THA)

This is a post-market, monocentric Retrospective and prospective, observational, open-label and baseline clinical study in order to evaluate the performance and safety of Revision LR femoral stem

Inclusion Criteria:

• Males and females of any race
• Age ≥ 18 years old
• A diagnosis or condition in the target hip of one or more of the following: Primary tumors or metastasis and relative outcomes; Advanced articular destruction generated by primary degenerative or post-traumatic arthrosis or rheumatoid arthritis;Fracture or avascular necrosis; Congenital or acquired deformity; Failures of previous operations, like osteosynthesis, articular reconstruction, arthrodesis, hemi-arthroplasty or total arthroplasty; Epiphyseal region general trauma, Willingness to comply with prescribed rehabilitation and study evaluation and ability to return for follow-up visits
• Signed study-specific Informed Consent Form

Exclusion Criteria:

• Acute or chronic infections, local or systemic infections,
• Septicaemia
• Persistent acute or chronic osteomyelitis
• Serious muscular, neurological or vascular diseases affecting the concerned limb
• Mass higher than 60 kg